ArticleSurgery today2019

BRF2 as a promising indicator for radical lymph-node dissection surgery in patients with cN0 squamous cell carcinoma of the middle thoracic esophagus.

Yu Tian et al.PubMed ↗Publisher ↗

No numbers read from the abstract.